HansBiomed Financials
| 042520 Stock | KRW 7,460 80.00 1.06% |
HansBiomed |
Understanding current and past HansBiomed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of HansBiomed's financial statements are interrelated, with each one affecting the others. For example, an increase in HansBiomed's assets may result in an increase in income on the income statement.
Please note, the presentation of HansBiomed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HansBiomed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of HansBiomed's management manipulating its earnings.
HansBiomed Stock Summary
HansBiomed competes with Samsung Electronics, Samsung Electronics, LG Energy, SK Hynix, and Samsung Biologics. HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea. HANS BIOMED is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7042520007 |
| Business Address | 7, Jeongui-ro 8-gil, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.hansbiomed.com |
| Phone | 82 2 466 2266 |
| Currency | KRW - South Korean Won |
You should never invest in HansBiomed without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of HansBiomed Stock, because this is throwing your money away. Analyzing the key information contained in HansBiomed's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
HansBiomed Key Financial Ratios
HansBiomed's financial ratios allow both analysts and investors to convert raw data from HansBiomed's financial statements into concise, actionable information that can be used to evaluate the performance of HansBiomed over time and compare it to other companies across industries.| Return On Equity | 13.65 | |||
| Return On Asset | -0.0946 | |||
| Target Price | 36333.0 | |||
| Number Of Employees | 15 | |||
| Beta | 0.26 |
HansBiomed Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HansBiomed's current stock value. Our valuation model uses many indicators to compare HansBiomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HansBiomed competition to find correlations between indicators driving HansBiomed's intrinsic value. More Info.HansBiomed is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value HansBiomed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HansBiomed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.HansBiomed Systematic Risk
HansBiomed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. HansBiomed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on HansBiomed correlated with the market. If Beta is less than 0 HansBiomed generally moves in the opposite direction as compared to the market. If HansBiomed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one HansBiomed is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of HansBiomed is generally in the same direction as the market. If Beta > 1 HansBiomed moves generally in the same direction as, but more than the movement of the benchmark.
HansBiomed November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of HansBiomed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of HansBiomed. We use our internally-developed statistical techniques to arrive at the intrinsic value of HansBiomed based on widely used predictive technical indicators. In general, we focus on analyzing HansBiomed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build HansBiomed's daily price indicators and compare them against related drivers.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 15.35 | |||
| Value At Risk | (4.65) | |||
| Potential Upside | 3.5 |
Complementary Tools for HansBiomed Stock analysis
When running HansBiomed's price analysis, check to measure HansBiomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HansBiomed is operating at the current time. Most of HansBiomed's value examination focuses on studying past and present price action to predict the probability of HansBiomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HansBiomed's price. Additionally, you may evaluate how the addition of HansBiomed to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |